Partial thromboplastin time
61 results
1 - 61
Partial thromboplastin time
Transfusion Therapy - Coagulation Studies- Russell viper venom time (dRVVT)
- ISOLATED PROLONGATION OF PTT: LABORATORY EVALUATION
- Transfusion Therapy - The Decision to Transfuse
telavancin- Protamine
- nusinersen
- BLEEDING DISORDERS, INHERITED: EVALUATION OF SUSPECTED INHERITED BLEEDING DISORDERS
- olaratumab
- Heparin—Unfractionated
- valdecoxib
- margetuximab
- Anesthesia for Cardiac Surgery - Preoperative Assessment for Cardiac Surgery
- velaglucerase alfa
- bazedoxifene/conjugated estrogens
- brigatinib
- drotrecogin
- Anesthesia for Spine Surgery - Blood Loss
- aprotinin
- fruquintinib
- ripretinib
- tafasitamab
- factor ix (human)
- anticoagulants
- Argatroban
- tivozanib
- emicizumab
- tisotumab vedotin
- antihemophilic factor
- aztreonam
- desirudin
- hetastarch
- argatroban
- pembrolizumab
- tirofiban
- meropenem
- BLEEDING DISORDERS: LABORATORY EVALUATION
- Alteplase
- Anesthesia for Obstetrics and Gynecology - Preeclampsia
- avapritinib
- Anesthesia for Trauma and Burns - Initial Evaluation of the Trauma Patient
- tenecteplase
- thrombolytics
- desmopressin
- anistreplase
- reteplase
- urokinase
- streptokinase
- alteplase
- piperacillin/tazobactam
- Normal Values of Common Laboratory Tests
Hematologic Tests, Diagnostic Interpretation- UNDERLYING ASSUMPTIONS
- Mechanical Support of the Failing Heart